Supreme Court focuses on ‘pay for delay’ deals
WASHINGTON—”Pay for delay” deals between big pharmaceutical companies and generic drug competitors are going before the United States Supreme Court.
Federal regulators are pressing the high court to stop big pharmaceutical companies from paying generic drug competitors to delay their releases of cheaper versions of brand name drugs.
The Obama Administration says the so-called “pay for delay” deals profit the drug companies while harming consumers by denying them price declines.
Instead, the deals add $3.5 billion each year to Americans’ drug bills.
- Oklahoma part of major beef recall, see if your neighborhood grocery store made the list
- Woman's car payments hid her death for 6 years, body found mummified in backseat of car
- TRAGIC: Man dies from injuries after being hit with his own vehicle
- Sandwich Suspension: 2-year-old girl punished by daycare over cheese sandwich
- PHOTO: Oklahoma Gov. daughter responds to photo stirring up controversy online